wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36223538-A87BE26E-2B4D-45DB-9629-4CD29CD9A751
Q36223538-A87BE26E-2B4D-45DB-9629-4CD29CD9A751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36223538-A87BE26E-2B4D-45DB-9629-4CD29CD9A751
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
P2860
Q36223538-A87BE26E-2B4D-45DB-9629-4CD29CD9A751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36223538-A87BE26E-2B4D-45DB-9629-4CD29CD9A751
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b7152ec16264a63e9b6ea93e71d84246476d7a5
P2860
New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma.